China Life Sciences Health Industry Client Briefing – April 2013 (May 15, 2013)

by Reed Smith

Pharmaceuticals, Medical Devices, Health Care & Life Sciences


Approval of Innovative Drugs and Key Sector Generic Drugs to be Expedited (Shanghai Securities Journal 2013-04-23)

Given the significance of generic drugs within China’s health care system, the duplication of generic drug research and development is a serious concern. Currently, certain generic drugs are facing both surplus and shortage problems in the domestic market. To address these problems, China’s Food and Drug Administration ("CFDA") intends to give priority to the examination and approval of both innovative drugs and key sector generic drugs, including anti-tumor, anti-tuberculosis, anti-HIV and cardiovascular drugs.

Guangzhou Pharma Case (Global Times 2013-04-08) – April 8, 2013

The Guangdong Food and Drug Administration ("GFDA") recently found that Guangzhou Pharmaceutical Co. compromised the safety of a medication widely used to cure the flu in China. Specifically, the GFDA found that the production of Vitamin C Yinqiao tablets was compromised through the illegal use of non-medicinal parts of the wild honeysuckle flower. In addition, the GFDA determined that the manufacturer, through its efforts to avoid government supervision, committed serious breaches of Chinese drug administration laws by forging relevant production records. The company’s production license has been revoked and those involved will be prosecuted for criminal liability.

Fosun Pharma to Acquire Israel-Based Medical Device Manufacturer (Caijing 2013-04-27) – April 27, 2013

Through a joint venture with Pramerica-Fosun China Opportunity Fund, L.P., Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun") recently announced that it will acquire Israel-based Alma Lasers Ltd. ("Alma"), with a 95.6 percent share of the company for approximately US$240 million. Alma is a well-known manufacturer of medical laser, photonic radiofrequency, and ultrasonic products, and whose high-end cosmetic laser devices account for 15 percent of the global market share. Last year, Alma’s revenue in China alone approached approximately 23 percent of its global revenue. Following the merger, Fosun will establish Alma as a management platform for the research and development, manufacturing, and sales of high-end medical devices.

Traditional Chinese Medicine ("TCM")

Beijing Hosts Traditional Chinese Medicine ("TCM") Training Program (China Daily 2013-04-16) – April 16, 2013

Despite the recent outbreak of cases of human infections with the avian influenza A (H7N9) virus in China, health officials from 14 countries in Asia traveled to Beijing to attend a 10-day Traditional Chinese Medicine ("TCM") training program. The program, which was launched April 15, was conducted by the Chinese National Health and Family Planning Commission. The program focused on sharing China’s perspectives and experiences with advancing TCM science, integrating the non-medicinal therapeutic techniques of TCM with modern medicine, and exploring efficient cooperative mechanisms among participant countries.

Medical Devices

Ministry of Industry and Information Technology ("MIIT") Supports Development of Medical Devices (Guangzhou Daily 2013-04-26)

The Ministry of Industry and Information Technology ("MIIT") will reportedly list medical devices as one of its "supported projects" for this year. As a result, the medical device companies included on the list may possibly benefit from subsidies granted by the MIIT. While the criteria to be used by MIIT in its selection of companies qualified to receive such subsidies is not yet known, given the great market potential for foreign medical device companies in China, it is reported that large foreign medical device companies – such as GE Healthcare – are trying to compete with Chinese companies through localization of their products.

Medical Reform

Changes in the Healthcare Industry (China Daily 2013-04-09) – April 10, 2013

The use of private health care is becoming increasingly popular in China. In addition to the use of private health care workers, more Chinese – particularly those living in urban areas – are willing to pay a higher price for the safety and convenience of private, professional nursing services.

Medical Reforms in China Attract Pharma Giants (China Daily 2013-04-13) – April 15, 2013

Given the large market potential and increased health care expenditures in China, many of the world’s leading international health care companies are quickly expanding their manufacturing capabilities in China, as well as looking for potential merger and acquisition opportunities. Last year alone, the government’s spending on health care expenditures rose by 27.1 percent. The government has also recently announced its plans to increase investments in preventing and treating chronic diseases, and to expand health care reimbursement by adding more medicines to the essential drugs list. As a result of these opportunities, more than 10 international health care companies launched new medicines and medical devices in China in late March.

State Council Issues Guiding Opinions on the Reform and Improvement of Local Food and Drug Supervision and Management (Central Government 2013-04-18)

In accordance with a plan adopted by the National People’s Congress ("NPC"), the State Council recently issued several opinions related to the reform of the local supervision mechanism established for food and drugs. The opinions require local governments to uniformly establish food and drug supervision agencies by combining a number of existing departments at the local level – including those departments overseeing safety, quality, and inspection within food and drug, as well as industry and commerce, administrations. The opinions also require regional inspection centers to be established. The food and drug administrations at the county levels may establish dispatch institutions within smaller municipalities, such as villages and towns, to assist with grassroots supervision. Furthermore, the food and drug administrations at the provincial, city and county levels must complete their reform efforts by the end of this year.


Healthcare Companies Promote Internet-Based Medical Services (China Daily 2013-04-13) – April 15, 2013 GE Healthcare, the medical arm of General Electric Co., is promoting its Internet-based medical technology and solutions in China. According to Rachel Duan, President and CEO of GE Healthcare China, GE Healthcare intends to use Internet-based long-distance imaging to care for patients, reduce costs, and increase efficiency. The multi-national medical device developer and manufacturer is not the only company testing the waters in Internet-based and mobile health care. Other foreign and domestic companies, such as Siemens Healthcare, Omron Medical Devices, and Mindray Medical International Ltd., have also adopted this strategy.

Internet-based telemedicare is a rapidly growing sector within the health care industry. According to a report from the Global System of Mobile Communications Association, mobile health care is expected to create $6.6 billion in revenue for medical device companies between 2012 and 2016.


Written by:

Reed Smith

Reed Smith on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.